Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

VJVirtual

01 August 2021

VJVirtual

01 August 2021
Increasing awareness of TA-TMA and therapeutic approaches 2:23
Increasing awareness of TA-TMA and therapeutic approaches
Sergio Giralt • 22 Feb 2021
TCT 2021: oxygen sensing, pediatric CAR-T & the microbiome 4:23
TCT 2021: oxygen sensing, pediatric CAR-T & the microbiome
Pavan Reddy • 24 Feb 2021
Outcomes of allogeneic stem cell transplantation in elderly patients 3:51
Outcomes of allogeneic stem cell transplantation in elderly patients
Yngvar Fløisand • 11 Feb 2021
ASTCT response to the COVID-19 pandemic 3:16
ASTCT response to the COVID-19 pandemic
Pavan Reddy • 24 Feb 2021
Narsoplimab for adult TA-TMA 0:46
Narsoplimab for adult TA-TMA
Sergio Giralt • 22 Feb 2021
Focus of the ASTCT in 2021 and beyond 2:25
Focus of the ASTCT in 2021 and beyond
Pavan Reddy • 24 Feb 2021
Engineering multi-antigenic CAR T-cells for AML 2:03
Engineering multi-antigenic CAR T-cells for AML
Sara Ghorashian • 7 Dec 2020
Limitations of ibrutinib and ruxolitinib use in cGVHD 1:05
Limitations of ibrutinib and ruxolitinib use in cGVHD
Carlos Bachier • 3 Dec 2020
CAR T-cell therapy for relapsed ALL with CNS involvement 1:55
CAR T-cell therapy for relapsed ALL with CNS involvement
Sara Ghorashian • 7 Dec 2020
Real-world outcomes following tisa-cel for R/R ALL: an intention-to-treat analysis 1:56
Real-world outcomes following tisa-cel for R/R ALL: an intention-to-treat analysis
Sara Ghorashian • 7 Dec 2020
First-line axicabtagene ciloleucel in lymphoma 0:34
First-line axicabtagene ciloleucel in lymphoma
Yago Nieto • 15 Feb 2021
PTCy in MMUD HCT: the University of Miami experience 5:38
PTCy in MMUD HCT: the University of Miami experience
Muhammad Husnain • 17 Feb 2021
The CIBMTR COVID-19 experience 3:10
The CIBMTR COVID-19 experience
Marcie Riches • 15 Feb 2021
Cord blood-derived NK cells with high-dose chemotherapy & ASCT for B-NHL 1:44
Cord blood-derived NK cells with high-dose chemotherapy & ASCT for B-NHL
Yago Nieto • 15 Feb 2021
Impact of MMRD and ELN genetic classification in outcomes for patients with AML underoging alloHCT 5:15
Impact of MMRD and ELN genetic classification in outcomes for patients with AML underoging alloHCT
Muhammad Husnain • 17 Feb 2021
Infusion of CD30 CAR T-cells following AuHCT in patients with lymphoma 1:42
Infusion of CD30 CAR T-cells following AuHCT in patients with lymphoma
Marcie Riches • 15 Feb 2021
The content of VJHemOnc is intended for healthcare professionals